Study: XLIF Can Be Expanded to the Thoracic Spine

The lateral lumbar interbody fusion, or extreme lateral interbody fusion, approach can be expanded to treat thoracic spine diseases, according to a study published in The Journal of Spinal Disorders & Techniques.

Advertisement

Researchers studied 22 patients with isolated thoracic and thoracolumbar spine disease using the XLIF technique. A total of 47 levels were treated in the patients, who were indicated for degenerative scoliosis, pathological fractures from tumors, adjacent level disease from prior fusion, thoracic disc herniation and discitis/osteomyelitis.

The average blood loss among the patients was 227.5 ML, and the average length of stay was 4.8 days. There were three complications recorded, one of which required an additional procedure. There was no neural, vascular, visceral injuries or death reported. All patients demonstrated good radiographic evidence of fusion.

There was less deformity correction achieved through this approach than the traditional surgeries, but the minimally invasive nature of XLIF makes it more tolerable for older patients or patients with significant comorbidities.

Read the abstract about XLIF.

Related Articles on XLIF:

XLIF Procedure Now Covered By CIGNA and Humana

10 Spine and Neurosurgeons Performing XLIF

Study: XLIF a Safe, Cost-Saving Spinal Procedure

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spine

Advertisement

Comments are closed.